However, research indicates that individuals with AATD, particularly those with genetic mutations resulting in insufficient AAT levels, exhibit elevated expression of matriptase (a membrane-bound serine protease) in their AMs 47. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.